Religare Appoints Dr. Anand Burman as Non-Executive Director

Dr. Anand Burman has been appointed as a Non-Executive, Non-Independent Director on the Board of Religare, following approval from the Reserve Bank of India. The appointment, effective November 3, 2026, strengthens the Board's leadership and governance.
Dr. Burman brings extensive experience in business leadership, pharmaceuticals, and consumer healthcare. He has been closely associated with the growth and evolution of Dabur India Limited, one of India's leading consumer healthcare businesses. He holds a PhD in Pharmaceutical Chemistry from the University of Kansas.
Share this article
Send it to a colleague or post it to your network.